Drug delivery research: The invention cycle

Molecular Pharmaceutics

Volumn 13, Issue 7, 2016, Pages 2143-2147

  Park, Kinam ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

drug delivery; imagination; innovation; invention cycle; translation

Indexed keywords

NUCLEIC ACID; PROTEIN; DELAYED RELEASE FORMULATION; DRUG;

DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; INVENTION; LABORATORY; MOLECULAR WEIGHT; PRIORITY JOURNAL; RESEARCH; REVIEW; ADMINISTRATION AND DOSAGE; CHEMISTRY; DELAYED RELEASE FORMULATION; MEDICINAL CHEMISTRY; PROCEDURES;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; INVENTIONS; PHARMACEUTICAL PREPARATIONS; PROTEINS;

EID: 84979031809     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.6b00015     Document Type: Review

References (25)

1. Lee, P. I. and Li, J.-X. Evolution of oral controlled release dosage forms. In Oral Controlled Release Formulation Design and Drug Delivery; Wen, H. and Park, K., Eds.; John Wiley & Sons, Inc.: Hoboken, NJ, 2010; pp 21-31.
2. Park, K. Controlled drug delivery systems: Past forward and future back J. Controlled Release 2014, 190 (0) 3-8 10.1016/j.jconrel.2014.03.054
3. Yun, Y. H.; Lee, B. K.; Park, K. Controlled drug delivery: Historical perspective for the next generation J. Controlled Release 2015, 219, 2-7 10.1016/j.jconrel.2015.10.005
4. Lee, B. K.; Yun, Y. H.; Park, K. Smart nanoparticles for drug delivery: Boundaries and opportunities Chem. Eng. Sci. 2015, 125 (0) 158-164 10.1016/j.ces.2014.06.042
5. Park, K. Drug delivery of the future: Chasing the invisible gorilla J. Controlled Release 2015, 10.1016/j.jconrel.2015.10.048
6. Amidon, G. L.; Lennernas, H.; Shah, V. P.; Crison, J. R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995-Backstory of BCS AAPS J. 2014, 16 (5) 894-898 10.1208/s12248-014-9620-9
7. Straubinger, R. M. Biopharmaceutics of paclitaxel (Taxol): Formulation, activity, and pharmacokinetics. In TAXOL® Science and Applications; Suffness, M., Ed.; CRC Press: Boa Raton, FL, 1995; pp 237-258.
8. Seelig, T. Insight Out. Get Ideas Out of Your Head and Into the World; HarperCollins Publishers: New York, NY, 2015.
9. Holmes, J. Nonsense: The Power of Not Knowing; Penguin Random House: New York, NY, 2015; p 322.
10. Gardner, D. Future Babble: Why Expert Predictions Fail-and Why We Believe Them Anyway; Penguin Group: New York, NY, 2011; p 305.
11. Stirland, D. L.; Nichols, J. W.; Miura, S.; Bae, Y. H. Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice J. Controlled Release 2013, 172 (3) 1045-1064 10.1016/j.jconrel.2013.09.026
12. Florence, A. T. Targeting" nanoparticles: The constraints of physical laws and physical barriers J. Controlled Release 2012, 164 (2) 115-124 10.1016/j.jconrel.2012.03.022
13. Florence, A. T. Reductionism and complexity in nanoparticle-vectored drug targeting J. Controlled Release 2012, 161 (2) 399-402 10.1016/j.jconrel.2011.11.005
14. Park, K. Facing the truth about nanotechnology in drug delivery ACS Nano 2013, 7, 7442-7447 10.1021/nn404501g
15. Park, K. Translation from mouse to human: Time to think in new boxes J. Controlled Release 2014, 189 (0) 187 10.1016/j.jconrel.2014.07.046
16. Nichols, J. W.; Bae, Y. H. EPR: Evidence and fallacy J. Controlled Release 2014, 190 (0) 451-464 10.1016/j.jconrel.2014.03.057
17. Pittampalli, A. Persuadable. How Great Leaders Change Their Minds to Change the World; HarperCollins Publishers: New York, NY, 2016; p 242.
18. Fisk, P. Creative Genius: An Innovation Guide for Business Leaders, Border Crossers and Game Changers; Capstone Publishing Ltd. (a Wiley Company): Chichester, West Sussex, United Kingdom, 2011; p 386.
19. Zimmer, E. Ideas vs. inventions. http://tenonline.org/art/9010.html.
20. Grasty, T. The difference between "invention" and "innovation". The Huffington Post 2012. http://www.huffingtonpost.com/tom-grasty/technological-inventions-and-innovation-b-1397085.html.
21. Khaled, S. A.; Burley, J. C.; Alexander, M. R.; Yang, J.; Roberts, C. J. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles J. Controlled Release 2015, 217, 308-314 10.1016/j.jconrel.2015.09.028
22. Park, K. 3D printing of 5-drug polypill J. Controlled Release 2015, 217, 352 10.1016/j.jconrel.2015.10.014
23. Barenholz, Y. Doxil®-The first FDA-approved nano-drug: Lessons learned J. Controlled Release 2012, 160 (2) 117-134 10.1016/j.jconrel.2012.03.020
24. Yardley, D. A. nab-Paclitaxel mechanisms of action and delivery J. Controlled Release 2013, 170 (3) 365-372 10.1016/j.jconrel.2013.05.041
25. Surowiecki, J. The Wisdom of Crowds; Anchor Books: New York, NY, 2005; p 306.